The dental bone graft substitutes market has been expected to rise USD 1.34 billion by 2030 at 8.9% CAGR over the estimated 2022-2030. Bone grafts and substitutes are utilized for replacing missing bones or repairing bone fractures. They comprise an osteoconductive matrix that acts as a filler to promote wound healing; osteoinductive proteins which support mitogenesis of identical bone cells; and osteogenic cells that form the bone in the appropriate environment. They are bioresorbable and cause no antigen-antibody reaction. Owing to these attributes, they are widely used to heal fractures and bone injuries and spinal, facial, foot, ankle or trauma surgeries.
One of the key trends witnessed in the market is the advent of new polymer and ceramic products with biologically superior characteristics. The introduction of new manufacturing technologies, such as rapid prototyping or 3D printing, is also helping in the fabrication of free-form biomaterial scaffolds for tissue regeneration. Additionally, the demand for bone grafts and substitutes is increasing owing to high morbidity rates, a growing senior population and the increasing cases of osteoarthritis. Apart from this, a shift towards minimally invasive procedures, coupled with the growing awareness among patients about the benefits of bone regeneration through biologics, further strengthens market growth.
The dental bone graft substitutes global market has been segmented into type, application, and end user.
Based on type, dental bone graft substitutes global market is segmented into allograft, xenograft, alloplast, and others.
Based on application, dental bone graft substitutes global market is segmented into ridge augmentation, sinus lift, socket preservation, periodontal defect, and implant bone regeneration.
Based on end user, dental bone graft substitutes global market is segmented into dental clinics, hospitals, and others. The dental clinics segment is expected to account for the largest share segment of the market in 2017.
The dental bone graft substitutes global market segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The dental bone graft substitutes market in the Americas further segmented into North America and South America, with the North American market divided into the US and Canada.
The European dental bone graft substitutes market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
This market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The dental bone graft substitutes market in the Middle East & Africa segmented into the Middle East and Africa.
Regional Market Summary
Geographically, Europe is anticipated to dominate the dental bone graft substitutes market owing to a well-established player and increasing incidence of oral diseases namely, dental caries and periodontal diseases.
The Americas is expected to hold the second largest position in the dental bone graft substitutes market. The market growth in this region is attributed to increasing incidence of oral diseases such as dental caries and periodontal diseases and growing ageing population.
The dental bone graft substitutes market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region. The market growth in this region is attributed to growing medical tourism in developing countries.
The Middle East & Africa has the least share of the dental bone graft substitutes market.
Market, by Type
Market, by Application
Market, by End User
Market, by Region
In March 2022, Fredun Pharmaceuticals Limited received approval to manufacture Xenografts for various dental and orthopedic surgical appliances from the Central Drugs Standard Control Organisation (COSCO), India. With this, the company aims to penetrate the dental fraternity across India. Such developments are expected to fuel the development of dental bone graft substitutes for xenografts, thereby boosting the segment's growth.
Furthermore, Dentsply Sirona acquired Datum Dental Ltd., known for innovative dental regeneration products, in January 2021. With this acquisition, Dentsply Sirona promotes the full OSSIX portfolio, including OSSIX Plus, OSSIX Volumax, and OSSIX Bone, in the United States, Canada, and several other countries.
|Market Size||USD 1.34 Bn|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Type, Application, And End User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Orthogen, LLC (US), LifeNet Health (US), Dentium (South Korea), Zimmer Biomet Dental (US), Medtronic Plc (Ireland), Institut Straumann AG (Switzerland), Dentsply Sirona (US), Geistlich Pharma AG (Switzerland), and Biohorizons Iph, Inc. (US)|
|Key Market Opportunities||Research & Development|
|Key Market Drivers||
Dental Bone Graft Substitutes Market is projected to grow at a 8.9% CAGR between 2022-2030.
Europe is expected to have a major share in the Dental Bone Graft Substitutes Market.
It has extensive applications in implant bone regeneration, periodontal defect, socket preservation, sinus lift, and ridge augmentation.
Leading players profiled in the Dental Bone Graft Substitutes Market include Orthogen, LLC (US), LifeNet Health (US), Dentium (South Korea), Zimmer Biomet Dental (US), Medtronic Plc (Ireland), Institut Straumann AG (Switzerland), Dentsply Sirona (US), Geistlich Pharma AG (Switzerland), and Biohorizons Iph, Inc. (US).
Stringent regulations and lack of proper reimbursement may limit market growth.